CD81 and breast cancer: After an extensive, critical literature review focused on the association of the aforementioned differentially expressed proteins with cancer development and prognostic value in solid cancers, including BC [23–31], we identified CREBBP and CD81, which have been investigated in a limited number of BC studies (less than 3), as representative upregulated and downregulated candidate biomarkers, respectively.